Insider
3M Co.MMM

3M to settle PFAS claims for $7.35 billion

3M agreed to pay $7.35 billion between 2026 and 2034 to resolve most personal injury claims related to PFAS. The agreement, signed on November 3, 2026, covers about 99% of current claims in the Aqueous Film-Forming Foam (AFFF) multidistrict litigation, involving up to 120,000 plaintiffs.

Verified against 4 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
A wooden rubber stamp resting on an open German legal document
Photo by Markus Spiske on Unsplash
$7.35 billion
Settlement amount
120,000
Plaintiffs involved
99%
Claims covered

Settlement terms

The company pledged to pay a total of $7.35 billion, including a $680 million reserve fund for future and unresolved claims. The payment schedule includes $50 million in 2026, no payments in 2027, and about 20% of the total due in the final two years of the term.

The settlement is not an admission of fault, liability, or wrongdoing by 3M. The company continues to deny all allegations of liability in these cases.

Next steps for shareholders

Implementation depends on plaintiff participation levels. If participation thresholds are not met, 3M or the plaintiffs may exercise termination rights, triggering the return of funds from the company's qualified settlement fund (QSF).

Original sources

  1. 8-K filing, November 4, 2026November 4, 2026SHA-256 of our archived copy 2255c40fcf47…
  2. 8-K EX-99.1 filing, November 4, 2026November 4, 2026SHA-256 of our archived copy c69f5268536c…
  3. 8-K EX-10.1A filing, November 4, 2026November 4, 2026SHA-256 of our archived copy 9cd34113a828…
  4. 8-K EX-10.1 filing, November 4, 2026November 4, 2026SHA-256 of our archived copy 3516db8d2db8…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards